VANGUARD GROUP INC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 1 filers reported holding UNUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,318,000
+470.6%
563,095
+12.0%
0.00%
Q2 2020$231,000
+6.5%
502,580
-4.1%
0.00%
Q1 2020$217,000
-42.6%
524,330
-0.1%
0.00%
Q4 2019$378,000
-50.1%
524,992
-0.2%
0.00%
Q3 2019$758,000
-29.1%
526,116
+29.0%
0.00%
Q2 2019$1,069,000
-44.9%
407,812
-7.7%
0.00%
Q1 2019$1,939,000
+138.8%
441,820
+139.6%
0.00%
Q4 2018$812,000
-85.7%
184,426
-66.6%
0.00%
Q3 2018$5,690,000
-25.2%
552,380
+4.2%
0.00%
Q2 2018$7,604,000
+82.9%
529,870
+41.6%
0.00%
Q1 2018$4,157,000374,1000.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$14,757,00013.86%
New Leaf Venture Partners, L.L.C. 1,795,545$7,882,0002.16%
SECTORAL ASSET MANAGEMENT INC 1,587,437$6,969,0000.84%
SABBY MANAGEMENT, LLC 206,358$906,0000.44%
COWEN INC. 817,395$3,588,0000.38%
Novo Holdings A/S 473,441$2,078,0000.31%
PLATINUM INVESTMENT MANAGEMENT LTD 260,595$1,144,0000.03%
WASATCH ADVISORS LP 254,449$1,117,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 109,075$479,0000.01%
FIL Ltd 783,423$3,439,0000.01%
View complete list of UNUM THERAPEUTICS INC shareholders